Description

Using the financial statements for Celgene Corporation and Gilead Sciences, Inc., respectively, you will calculate and compare the financial ratios listed further down this document for the fiscal year ending 2015, and prepare your comments about the two companies performances based on your ratio calculations.

Overall Requirements

Your final Excel workbook submission should contain the following. You cannot use any other software but Excel to complete this project. A Completed Worksheet Title Page tab, which is really a cover sheet with your name, the course, the date, your instructors name, and the title for the project.

A Completed Worksheet Profiles tab which contains a one-paragraph description regarding each company with information about their history, what products they sell, where they are located, and so forth.

All 3 ratios for each company with the supporting calculations and commentary on your Worksheet Ratio tab. Supporting calculations must be shown either as a formula or as text typed into a different cell. The ratios are listed further down this document. Your comments for each ratio should include more than just a definition of the ratio. You should focus on interpreting each ratio number for each company and support your comments with the numbers found in the ratios. You need to specifically state which company performed better for each ratio.

Required Ratios for Final Project Submission:

Rate of Return on Total Assets (ROA)

Dividend Yield [For the purposes of this ratio, use Yahoo Finance to look up current dividend per share and stock price; just note the date that you looked up this information.]

Rate of Return on Common Stockholders Equity (ROE)

GILEAD SCIENCES INC INCOME STATEMENT Period End: Dec 31, 2015 Date Filed: Feb1, 2016 SELECTED CONSOLIDATED FINANCIAL DATA Year Ended December 31 CONSOLIDATED STATEMENT OF INCOME DATA Total revenues (1) Total costs and espenses (1) Provision for income taxes Net income attributable to Gilead Net income per share attributable to Gilead Shares used in per share calculation-basic Net income per share attributable to Gilead Shares used in per share calculation-diluted Cash dividends declared per share 9 SELECTED CONSOLIDATED FINANCIAL DATA December 31 As of December 31, CONSOLIDATED BALANCE SHEET DATA Cash, cash equivalents and marketable 6,55190 $7,546.70 $5,687.00 17,340.10 Other long-term obligations (3) Senior unsecured notes, convertible senior